|
1
|
Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement.
|
Ann Intern Med
|
2006
|
6.34
|
|
2
|
Researching complementary and alternative treatments--the gatekeepers are not at home.
|
BMC Med Res Methodol
|
2007
|
2.96
|
|
3
|
Advising patients who seek complementary and alternative medical therapies for cancer.
|
Ann Intern Med
|
2002
|
2.29
|
|
4
|
Whole systems research: a discipline for studying complementary and alternative medicine.
|
Altern Ther Health Med
|
2003
|
2.05
|
|
5
|
Complementary and alternative medicine in undergraduate medical education. Associate deans' perspectives.
|
Can Fam Physician
|
2004
|
2.03
|
|
6
|
Complementary and alternative medicine whole systems research: beyond identification of inadequacies of the RCT.
|
Complement Ther Med
|
2005
|
1.97
|
|
7
|
U.S. and Canadian pharmacists' attitudes, knowledge, and professional practice behaviors toward dietary supplements: a systematic review.
|
BMC Complement Altern Med
|
2006
|
1.71
|
|
8
|
Integrating complementary and alternative medicine into academic medical centers: experience and perceptions of nine leading centers in North America.
|
BMC Health Serv Res
|
2005
|
1.71
|
|
9
|
Interprofessional collaboration within Canadian integrative healthcare clinics: Key components.
|
Soc Sci Med
|
2009
|
1.53
|
|
10
|
Improving the quality of reporting of randomized controlled trials evaluating herbal interventions: implementing the CONSORT statement [corrected].
|
Explore (NY)
|
2006
|
1.47
|
|
11
|
Superstition but not distrust in the medical system predicts the use of complementary and alternative medicine in a group of patients with acute leukemia.
|
Leuk Lymphoma
|
2008
|
1.42
|
|
12
|
Canadian pharmacy students' knowledge of herbal medicine.
|
Am J Pharm Educ
|
2008
|
1.35
|
|
13
|
Quality of reporting of randomized controlled trials of herbal medicine interventions.
|
Am J Med
|
2006
|
1.31
|
|
14
|
Investigating clinical heterogeneity in systematic reviews: a methodologic review of guidance in the literature.
|
BMC Med Res Methodol
|
2012
|
1.29
|
|
15
|
Moving forward? Complementary and alternative practitioners seeking self-regulation.
|
Sociol Health Illn
|
2004
|
1.27
|
|
16
|
How far can complementary and alternative medicine go? The case of chiropractic and homeopathy.
|
Soc Sci Med
|
2006
|
1.21
|
|
17
|
Recommendations for reporting randomized controlled trials of herbal interventions: Explanation and elaboration.
|
J Clin Epidemiol
|
2006
|
1.20
|
|
18
|
Acupuncture as a promising treatment for below-level central neuropathic pain: a retrospective study.
|
J Spinal Cord Med
|
2003
|
1.16
|
|
19
|
The use of CAM by women suffering from nausea and vomiting during pregnancy.
|
BMC Complement Altern Med
|
2002
|
1.15
|
|
20
|
Integrative health care: how can we determine whether patients benefit?
|
J Altern Complement Med
|
2005
|
1.12
|
|
21
|
St John's wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist.
|
Psychosomatics
|
2003
|
1.10
|
|
22
|
A survey of attitudes towards paediatric vaccinations amongst Canadian naturopathic students.
|
Vaccine
|
2004
|
1.10
|
|
23
|
The role of the state in the social inclusion of complementary and alternative medical occupations.
|
Complement Ther Med
|
2004
|
1.08
|
|
24
|
Addressing the emergence of pediatric vaccination concerns: recommendations from a Canadian policy analysis.
|
Can J Public Health
|
2006
|
1.08
|
|
25
|
Boswellia: an evidence-based systematic review by the Natural Standard Research Collaboration.
|
J Herb Pharmacother
|
2004
|
1.07
|
|
26
|
Mothers' beliefs about analgesia during childhood immunization.
|
Paediatr Child Health
|
2010
|
1.07
|
|
27
|
The Canadian Natural Health Products (NHP) regulations: industry perceptions and compliance factors.
|
BMC Health Serv Res
|
2006
|
1.06
|
|
28
|
Core competencies in natural health products for Canadian pharmacy students.
|
Am J Pharm Educ
|
2010
|
1.03
|
|
29
|
Study of natural health product adverse reactions (SONAR): active surveillance of adverse events following concurrent natural health product and prescription drug use in community pharmacies.
|
PLoS One
|
2012
|
1.02
|
|
30
|
Designing a framework for the delivery of collaborative musculoskeletal care involving chiropractors and physicians in community-based primary care.
|
J Interprof Care
|
2010
|
1.02
|
|
31
|
Multischool, international survey of medical students' attitudes toward "holism".
|
Acad Med
|
2005
|
1.01
|
|
32
|
Interprofessional collaboration within integrative healthcare clinics through the lens of the relationship-centered care model.
|
J Interprof Care
|
2010
|
1.01
|
|
33
|
Pharmacists' participation in research: a case of trying to find the time.
|
Int J Pharm Pract
|
2010
|
0.98
|
|
34
|
Consumers of natural health products: natural-born pharmacovigilantes?
|
BMC Complement Altern Med
|
2010
|
0.98
|
|
35
|
Responses of established healthcare to the professionalization of complementary and alternative medicine in Ontario.
|
Soc Sci Med
|
2004
|
0.97
|
|
36
|
CAM in Canada: places, practices, research.
|
Complement Ther Clin Pract
|
2005
|
0.96
|
|
37
|
Roles and responsibilities of pharmacists with respect to natural health products: key informant interviews.
|
Res Social Adm Pharm
|
2009
|
0.95
|
|
38
|
Characteristics of pediatric and adolescent patients attending a naturopathic college clinic in Canada.
|
Pediatrics
|
2005
|
0.94
|
|
39
|
Practitioners' validation of framework of team-oriented practice models in integrative health care: a mixed methods study.
|
BMC Health Serv Res
|
2010
|
0.94
|
|
40
|
Pharmacists and Natural Health Products: A systematic analysis of professional responsibilities in Canada.
|
Pharm Pract (Granada)
|
2008
|
0.93
|
|
41
|
The status of complementary therapy services in Canadian palliative care settings.
|
Support Care Cancer
|
2007
|
0.92
|
|
42
|
Ontario family physician readiness to collaborate with community pharmacists on drug therapy management.
|
Res Social Adm Pharm
|
2010
|
0.92
|
|
43
|
Guggul for hyperlipidemia: a review by the Natural Standard Research Collaboration.
|
Complement Ther Med
|
2005
|
0.90
|
|
44
|
Women's decision-making about their health care: views over the life cycle.
|
Patient Educ Couns
|
2002
|
0.90
|
|
45
|
Herbal remedy clinical trials in the media: a comparison with the coverage of conventional pharmaceuticals.
|
BMC Med
|
2008
|
0.88
|
|
46
|
Evidence-based systematic review of saw palmetto by the Natural Standard Research Collaboration.
|
J Soc Integr Oncol
|
2006
|
0.88
|
|
47
|
Trial of Essiac to ascertain its effect in women with breast cancer (TEA-BC).
|
J Altern Complement Med
|
2006
|
0.88
|
|
48
|
Kava monograph: a clinical decision support tool.
|
J Herb Pharmacother
|
2002
|
0.87
|
|
49
|
Inhibition of human cytochrome p450 metabolism by blended herbal products and vitamins.
|
J Pharm Pharm Sci
|
2011
|
0.87
|
|
50
|
Safety review of kava (Piper methysticum) by the Natural Standard Research Collaboration.
|
Expert Opin Drug Saf
|
2005
|
0.85
|
|
51
|
Horse chestnut:a multidisciplinary clinical review.
|
J Herb Pharmacother
|
2002
|
0.85
|
|
52
|
Reporting natural health product related adverse drug reactions: is it the pharmacist's responsibility?
|
Int J Pharm Pract
|
2011
|
0.84
|
|
53
|
Pharmacy study of natural health product adverse reactions (SONAR): a cross-sectional study using active surveillance in community pharmacies to detect adverse events associated with natural health products and assess causality.
|
BMJ Open
|
2014
|
0.83
|
|
54
|
Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial.
|
BMC Complement Altern Med
|
2011
|
0.83
|
|
55
|
Introducing medical students to CAM: response to Oppel et al.
|
Can Fam Physician
|
2005
|
0.82
|
|
56
|
Andrographis paniculata for the treatment of upper respiratory infection: a systematic review by the natural standard research collaboration.
|
Explore (NY)
|
2006
|
0.82
|
|
57
|
Adverse event reporting for herbal medicines: a result of market forces.
|
Healthc Policy
|
2009
|
0.82
|
|
58
|
New Canadian natural health product regulations: a qualitative study of how CAM practitioners perceive they will be impacted.
|
BMC Complement Altern Med
|
2006
|
0.81
|
|
59
|
Black cohosh (Cimicifuga racemosa [L.] Nutt.): safety and efficacy for cancer patients.
|
Support Care Cancer
|
2007
|
0.81
|
|
60
|
An evidence-based systematic review of bilberry (Vaccinium myrtillus) by the Natural Standard Research Collaboration.
|
J Diet Suppl
|
2009
|
0.81
|
|
61
|
Understanding the role of scientific evidence in consumer evaluation of natural health products for osteoarthritis an application of the means end chain approach.
|
BMC Complement Altern Med
|
2012
|
0.81
|
|
62
|
Redefining the randomized controlled trial in the context of acupuncture research.
|
Complement Ther Clin Pract
|
2006
|
0.81
|
|
63
|
Prescribing gabapentin off label: Perspectives from psychiatry, pain and neurology specialists.
|
Can Pharm J (Ott)
|
2012
|
0.80
|
|
64
|
An empirical study using permutation-based resampling in meta-regression.
|
Syst Rev
|
2012
|
0.80
|
|
65
|
Increased bruising with the combination of long-chain omega-3 fatty acids, flaxseed oil and clopidogrel.
|
Can Pharm J (Ott)
|
2013
|
0.79
|
|
66
|
Measurement properties of questionnaires assessing complementary and alternative medicine use in pediatrics: a systematic review.
|
PLoS One
|
2012
|
0.79
|
|
67
|
Polypharmacy, multiple natural health products and hepatotoxicity.
|
CMAJ
|
2011
|
0.79
|
|
68
|
State-space grid analysis: applications for clinical whole systems complementary and alternative medicine research.
|
Forsch Komplementmed
|
2012
|
0.79
|
|
69
|
How well do pharmacists know their patients? A case report highlighting natural health product disclosure.
|
Can Pharm J (Ott)
|
2013
|
0.79
|
|
70
|
Media portrayal of conflicts of interest in herbal remedy clinical trials.
|
Health Law Rev
|
2006
|
0.79
|
|
71
|
Parental views on pediatric vaccination: the impact of competing advocacy coalitions.
|
Public Underst Sci
|
2008
|
0.78
|
|
72
|
Lemon balm (Melissa officinalis L.): an evidence-based systematic review by the Natural Standard Research Collaboration.
|
J Herb Pharmacother
|
2005
|
0.78
|
|
73
|
Interpretation in cross-language research: tongues-tied in the health care interview?
|
J Cross Cult Gerontol
|
2013
|
0.77
|
|
74
|
Randomized controlled trials of herbal interventions underreport important details of the intervention.
|
J Clin Epidemiol
|
2011
|
0.76
|
|
75
|
Shark cartilage monograph: a clinical decision support tool.
|
J Herb Pharmacother
|
2002
|
0.75
|
|
76
|
The role of natural health products (NHPs) in dietetic practice: results from a survey of Canadian dietitians.
|
BMC Complement Altern Med
|
2013
|
0.75
|
|
77
|
The Canadian Natural Health Products (NHP) regulations: industry compliance motivations.
|
Evid Based Complement Alternat Med
|
2006
|
0.75
|
|
78
|
Where does homeopathy fit in pharmacy practice?
|
Am J Pharm Educ
|
2007
|
0.75
|
|
79
|
2016 INCAM Research Symposium: Expanding Person-Centred Care through Integrative Health Research.
|
J Complement Integr Med
|
2016
|
0.75
|
|
80
|
Barriers and facilitators to adherence to anti-diabetic medications: Ethiopian patients' perspectives.
|
Afr J Prim Health Care Fam Med
|
2017
|
0.75
|
|
81
|
Developing an operational model for an integrative oncology program: a qualitative descriptive feasibility study.
|
Support Care Cancer
|
2013
|
0.75
|
|
82
|
An open-label pilot study of homeopathic treatment of attention deficit hyperactivity disorder in children and youth.
|
Forsch Komplementmed
|
2014
|
0.75
|
|
83
|
An evidence-based systematic review of passion flower (Passiflora incarnata L.) by the Natural Standard Research Collaboration.
|
J Diet Suppl
|
2008
|
0.75
|
|
84
|
The professionalization of Western herbalists: response to new product regulations in Canada.
|
Complement Ther Med
|
2007
|
0.75
|